When was Halberd Pharmaceuticals founded?

Halberd Pharmaceuticals was founded in 2015.

Where is Halberd Pharmaceuticals located?

Halberd Pharmaceuticals is headquartered in Ernakulam, India.

Where does Halberd Pharmaceuticals rank among its competitors?

Halberd Pharmaceuticals ranks 1765th amongst 1873 active competitors, of which 96 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of Halberd Pharmaceuticals?

Halberd Pharmaceuticals' top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

Halberd Pharmaceuticals - 2026 Company Profile & Competitors

Company Details

Manufacturer of specialty pharmaceutical products and affordable human medicinal treatments. This organization produces various medications intended for healthcare applications. The business maintains distribution operations for pharmaceutical goods to provide access to medical supplies.

Key Metrics

Founded Year

2015

Location

Ernakulam, India

Stage

Unfunded

Ranked

1765^th among 1873 active competitors

Similar Companies

AbbVie & 1901 more

View Halberd Pharmaceuticals' full profile

Halberd Pharmaceuticals has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Halberd Pharmaceuticals include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of Halberd Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal Ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	71/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
1765th	Halberd Pharmaceuticals 2015, Ernakulam (India), Unfunded	Manufacturer of specialty pharmaceutical products and affordable human medicinal treatments	-	-	16/100